4.2 Review

Metabolic Biomarkers in Heart Failure

期刊

HEART FAILURE CLINICS
卷 14, 期 1, 页码 109-+

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.hfc.2017.08.011

关键词

Heart failure metabolomics; Arginine; Nitric oxide; Myocardial energy utilization; Acylcarnitine; TMAO

资金

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126827, P20HL113452] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106000] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [P20 HL113452, R01 HL126827] Funding Source: Medline
  4. NIDDK NIH HHS [R01 DK106000] Funding Source: Medline

向作者/读者索取更多资源

Metabolomics is the study of small, organic molecules within biochemical pathways. With advancement of technology, nuclear magnetic resonance, gas chromatography, and mass spectrometry have allowed for the discovery and analysis of large databases of metabolites implicated in heart failure. Metabolomics also explores the patient and environmental interactions and unlocks the link between environmental exposures and the development of cardiovascular disease. Although a relatively new field, metabolomics is poised to become a clinically impactful field that develops novel biomarkers and explores new therapeutic interventions in heart failure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据